VAROLI, LUCILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.817
AS - Asia 1.375
EU - Europa 1.080
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 59
SA - Sud America 51
OC - Oceania 1
Totale 4.497
Nazione #
US - Stati Uniti d'America 1.781
VN - Vietnam 443
CN - Cina 372
SG - Singapore 316
GB - Regno Unito 246
DE - Germania 162
IT - Italia 122
SE - Svezia 113
UA - Ucraina 102
IN - India 79
FR - Francia 73
HK - Hong Kong 65
RU - Federazione Russa 53
NL - Olanda 52
TG - Togo 39
BR - Brasile 38
IE - Irlanda 38
CI - Costa d'Avorio 27
CA - Canada 26
JP - Giappone 24
BG - Bulgaria 23
EE - Estonia 22
FI - Finlandia 20
BE - Belgio 16
ZA - Sudafrica 16
KR - Corea 14
SC - Seychelles 14
NG - Nigeria 11
ES - Italia 8
IQ - Iraq 8
PH - Filippine 8
IR - Iran 7
JO - Giordania 7
LT - Lituania 7
TR - Turchia 7
AT - Austria 6
AR - Argentina 5
BD - Bangladesh 5
GR - Grecia 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
MX - Messico 3
PL - Polonia 3
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
SA - Arabia Saudita 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
GD - Grenada 1
GI - Gibilterra 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
LC - Santa Lucia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.438
Città #
Dong Ket 237
Ashburn 217
Singapore 211
Southend 204
Chandler 167
Fairfield 150
San Jose 95
Woodbridge 81
Jacksonville 75
Ann Arbor 74
Santa Clara 74
Houston 69
Seattle 68
Wilmington 68
Hong Kong 62
Cambridge 58
Hanoi 55
Ho Chi Minh City 52
Princeton 52
Lomé 39
Beijing 38
Boardman 38
Dublin 38
New York 32
Hefei 30
Bologna 29
Abidjan 27
Lauterbourg 25
Padova 25
Nanjing 24
Westminster 23
Bremen 22
Council Bluffs 22
Sofia 22
Los Angeles 21
Berlin 20
Hyderabad 20
Tokyo 20
Helsinki 18
Brussels 16
Jinan 16
Saint Petersburg 16
Buffalo 14
Guangzhou 14
Mülheim 12
Shanghai 12
Toronto 12
Abeokuta 11
Da Nang 11
Mahé 11
Changsha 10
Frankfurt am Main 10
Leawood 10
Redwood City 10
Shenyang 10
Hebei 9
Seoul 9
Tianjin 9
Zhengzhou 9
Haiphong 8
London 8
Medford 8
Munich 8
Nanchang 8
Amman 7
Madrid 7
San Francisco 7
The Dalles 7
Dallas 6
Des Moines 6
Milan 6
Phoenix 6
Chengdu 5
Düsseldorf 5
Monmouth Junction 5
Montreal 5
Orem 5
Ottawa 5
Pune 5
San Diego 5
São Paulo 5
Taizhou 5
Bắc Giang 4
Can Tho 4
Caserta 4
Chennai 4
Chicago 4
Chongqing 4
Hải Dương 4
Jiaxing 4
Kunming 4
Las Vegas 4
Napoli 4
Portsmouth 4
Redondo Beach 4
Taiyuan 4
Verona 4
Yubileyny 4
Atlanta 3
Baoding 3
Totale 3.045
Nome #
Antitumor activity and COMPARE analysis of bis-indole derivatives 246
Antitumor Activity of New Substituted 3-(5-Imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-Imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: Selectivity Against Colon Tumor Cells and Effect on Cell Cycle-Related Events. 229
Antitumor Activity of Bis-indole Derivatives 222
Diphenidol-related diamines as novel muscarinic M4 receptor antagonists 221
Bis-guanylhydrazone diimidazo[1,2-a:1,2-c]pyrimidine as a novel and specific G-quadruplex binding motif 221
Antitumor Activity of Substituted E-3-(3,4,5-Trimethoxybenzylidene)-1,3-dihydroindol-2-ones 219
SUBSTITUTED E-3-(3-INDOLYLMETHYLENE)1,3-DIHYDROINDOL-2-ONES WITH ANTITUMOR ACTIVITY. IN-DEPTH STUDY OF THE EFFECT ON GROWTH OF BREAST CANCER CELLS. 214
Substituted E-3-(3-Indolylmethylene)-1,3-dihydroindol-2-ones with Antitumor Activity. In Depth Study of the Effect on Growth of Breast Cancer Cells 202
Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors 202
Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors 199
New isatin derivatives with antioxidant activity 197
New Antitumor Imidazo[2,1-b]thiazole Guanylhydrazones and Analogues 195
Antitumor activity of imidazo[2,1-b]thiazole guanylhydrazones and analogs. 194
Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis. 187
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 181
Benzoindol-2-one derivatives inducing mitochondria-mediated apoptosis associated with magnesium content decrease 174
Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, citotoxic activity, and study of the mechanism of action. 163
New substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity 161
Substituted (E)-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones as antitumor agents: SARs and study of the mechanism of action 159
Synthesis and antitumor activity of Guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1-b]thiazoles 158
Synthesis and chemiluminescent high throughput microassay for inhibition of acetylcholinesterase and butyrylcholinesterase activity by imidazo[2,1-b]thiazole derivatives 154
Antitumor activity of bis-indolinone derivatives. 150
SYNTHESIS OF 3-(5-IMIDAZO[2,1-b]THIAZOLYLMETHYLENE)-2-INDOLINONES INHIBITING TUBULIN ASSEMBLY AND INDUCING APOPTOSIS IN HT-29 COLON CANCER CELLS 118
Synthesis and antimicrobial activity of new diazoimidazole derivatives containing an N-acylpyrrolidine ring 81
Synthesis and biological profile at muscarinic M2 and M3 receptor subtypes of some analogs of diphenidol 50
Totale 4.497
Categoria #
all - tutte 11.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022443 48 19 7 23 38 30 15 30 22 35 97 79
2022/2023594 57 121 24 106 42 48 9 36 80 10 49 12
2023/2024166 11 26 9 8 6 74 5 10 2 9 0 6
2024/2025566 32 58 47 17 128 30 76 23 2 76 10 67
2025/20261.221 135 109 89 91 164 74 101 23 230 118 50 37
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 4.497